Grace Capital’s Dermira, Inc. DERM Stock Holding History

Grace Capital’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-16,700	Closed	-$153K	–	228
2018 Q2	$153K	Buy	+16,700	New	+$156K	0.06%	179

Other funds holding DERM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Grace Capital's DERM Position: Q3 2018 in Review

Grace Capital sold out of Dermira, Inc. (DERM) in Q3 2018, closing a stake of 16,700 shares — an estimated $153K sold.

Grace Capital first reported a position in DERM in Q2 2018 and held it in 1 quarter. The position peaked at $153K in Q2 2018. 105 funds tracked by Wall St. Rank hold DERM as of Q3 2018.

Grace Capital reported no remaining Dermira, Inc. position as of Q3 2018 after selling out during the quarter.
Grace Capital sold 16,700 Dermira, Inc. shares in Q3 2018, an estimated $153K.
Grace Capital first reported a position in Dermira, Inc. in Q2 2018 and held it in 1 quarter.
Grace Capital's Dermira, Inc. position peaked at $153K in Q2 2018.
105 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2018.

Based on Grace Capital's 13F filing for Q3 2018, filed 14 Nov 2018.